Gene · 917
Papers1,874
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 1,874
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Nasopharyngeal Carcinoma Subtype Discovery via Immune Cell Scores from Tumor Microenvironment. | J Immunol Res | 2023 | 37274867 | PubTator, text mining | PubMed |
| Integrated bioinformatics analysis for identifying key genes and pathways in female and male patients with dilated cardiomyopathy. | Sci Rep | 2023 | 37268658 | PubTator, text mining | PubMed |
| Cellular activation pathways and interaction networks in vascularized composite allotransplantation. | Front Immunol | 2023 | 37266446 | PubTator, text mining | PubMed |
| Identifying Novel Drug Targets for Epilepsy Through a Brain Transcriptome-Wide Association Study and Protein-Wide Association Study with Chemical-Gene-Interaction Analysis. | Mol Neurobiol | 2023 | 37246165 | PubTator, text mining | PubMed |
| LAPTM4B-YAP loop feedback amplification enhances the stemness of hepatocellular carcinoma. | iScience | 2023 | 37213231 | PubTator, text mining | PubMed |
| pYtags enable spatiotemporal measurements of receptor tyrosine kinase signaling in living cells. | Elife | 2023 | 37212240 | PubTator, text mining | PubMed |
| A prediction model identifying glycolysis signature as therapeutic target for psoriasis. | Front Immunol | 2023 | 37205116 | PubTator, text mining | PubMed |
| The effect of FMT and vitamin C on immunity-related genes in antibiotic-induced dysbiosis in mice. | PeerJ | 2023 | 37193034 | PubTator, text mining | PubMed |
| A prognostic model based on gene expression parameters predicts a better response to bortezomib-containing immunochemotherapy in diffuse large B-cell lymphoma. | Front Oncol | 2023 | 37188190 | PubTator, text mining | PubMed |
| Immunoengineered MXene nanosystem for mitigation of alloantigen presentation and prevention of transplant vasculopathy. | Nano Today | 2023 | 37187503 | PubTator, text mining | PubMed |
Neoadjuvant intratumoral influenza vaccine treatment in patients with proficient mismatch repair colorectal cancer leads to increased tumor infiltration of CD8+ T cells and upregulation of PD-L1: a phase 1/2 clinical trial. | J Immunother Cancer | 2023 | 37172969 | PubTator, text mining | PubMed |
| Biophysical and mechanobiological considerations for T-cell-based immunotherapy. | Trends Pharmacol Sci | 2023 | 37172572 | PubTator, text mining | PubMed |
| DNA ultra-sensitive quantification, a technology for studying HIV unintegrated linear DNA. | Cell Rep Methods | 2023 | 37159665 | PubTator, text mining | PubMed |
| Identification of potential resistance mechanisms and therapeutic targets for the relapse of BCMA CAR-T therapy in relapsed/refractory multiple myeloma through single-cell sequencing. | Exp Hematol Oncol | 2023 | 37158921 | PubTator, text mining | PubMed |
| Single-cell atlas reveals a distinct immune profile fostered by T cell-B cell crosstalk in triple negative breast cancer. | Cancer Commun (Lond) | 2023 | 37158690 | PubTator, text mining | PubMed |
| Transcriptomic insights into adenoid cystic carcinoma via RNA sequencing. | Front Genet | 2023 | 37152992 | PubTator, text mining | PubMed |
| Exploration of spatial heterogeneity of tumor microenvironment in nasopharyngeal carcinoma via transcriptional digital spatial profiling. | Int J Biol Sci | 2023 | 37151882 | PubTator, text mining | PubMed |
| Interaction gene set between osteoclasts and regulatory CD4+ T cells can accurately predict the prognosis of patients with osteosarcoma. | Cancer Sci | 2023 | 37150900 | PubTator, text mining | PubMed |
| Catch bond models may explain how force amplifies TCR signaling and antigen discrimination. | Nat Commun | 2023 | 37147290 | PubTator, text mining | PubMed |
| Single-cell sequencing of immune cells after marathon and symptom-limited cardiopulmonary exercise. | iScience | 2023 | 37123249 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/917/papers?page=14